| 摘要 |
The present invention relates to oligomer compounds (oligomers), which target the androgen receptor mRNA in a cell, leading to reduced expression of the androgen receptor. Reduction of the androgen receptor expression is beneficial for the treatment of certain medical disorders, such as a disease or a medical disorder as disclosed herein, such as a hyperproliferative disorder, such as cancer.
|
